About Us

Developing and review of the Formulary

Print page
The content of the Formulary is maintained with the support of Panels for Prescribing Advice (PPA). Each PPA includes Hospital Specialists, General Practitioners and Community Pharmacists. 
PPAs meet and consider current prescribing patterns, the most recent clinical evidence, patient safety and acceptability, and cost effectiveness when making their recommendations.
 
The proposals from the PPAs are then approved by the Prescribing Guidance Editorial Group.  
 
Chapters are reviewed regularly. Each chapter will have a proactive review approximately every 2-3 years, with more frequent updates if new evidence becomes available.
 

​Please see the HSCB and PHA Process for Developing Prescribing Guidance and Formulary Chapters for further details.  

Content on the NI Formulary website is not permitted to be used for commercial / promotional purposes